Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. Read more about Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis.
Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. Read more about Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results. Read more about Mesothelin-targeting T cell receptor fusion construct cell therapy in refractory solid tumors: phase 1/2 trial interim results.
Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results. Read more about Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results.
An integrated cell atlas of the lung in health and disease. Read more about An integrated cell atlas of the lung in health and disease.
Genetically adjusted PSA levels for prostate cancer screening. Read more about Genetically adjusted PSA levels for prostate cancer screening.
An integrated tumor, immune and microbiome atlas of colon cancer. Read more about An integrated tumor, immune and microbiome atlas of colon cancer.
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. Read more about Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial.
Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. Read more about Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging. Read more about Artificial-intelligence-based molecular classification of diffuse gliomas using rapid, label-free optical imaging.
